199 related articles for article (PubMed ID: 32476934)
1. Diagnostic management of occult nodal lymphangioleiomyomatosis detected during pelvic cancer staging. Localized finding or systemic disease?
Remo A; Zanella C; Parcesepe P; Greco F; Pancione M; Zapparoli MM; Manfrin E; Micheletto C
Sarcoidosis Vasc Diffuse Lung Dis; 2019; 36(1):33-38. PubMed ID: 32476934
[TBL] [Abstract][Full Text] [Related]
2. Incidental Pelvic and Para-aortic Lymph Node Lymphangioleiomyomatosis Detected During Surgical Staging of Pelvic Cancer in Women Without Symptomatic Pulmonary Lymphangioleiomyomatosis or Tuberous Sclerosis Complex.
Rabban JT; Firetag B; Sangoi AR; Post MD; Zaloudek CJ
Am J Surg Pathol; 2015 Aug; 39(8):1015-25. PubMed ID: 25786086
[TBL] [Abstract][Full Text] [Related]
3. Incidental Nodal Lymphangioleiomyomatosis Is Not a Harbinger of Pulmonary Lymphangioleiomyomatosis: A Study of 19 Cases With Evaluation of Diagnostic Immunohistochemistry.
Schoolmeester JK; Park KJ
Am J Surg Pathol; 2015 Oct; 39(10):1404-10. PubMed ID: 26135558
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological analysis of clinically occult extrapulmonary lymphangioleiomyomatosis in intra-pelvic and para-aortic lymph nodes associated with pelvic malignant tumors: A study of nine patients.
Uehara K; Kawakami F; Hirose T; Morita H; Kudo E; Yasuda M; Märkl B; Zen Y; Itoh T; Imai Y
Pathol Int; 2019 Jan; 69(1):29-36. PubMed ID: 30688413
[TBL] [Abstract][Full Text] [Related]
5. Incidental lymphangioleiomyomatosis in the lymph nodes of gynecologic surgical specimens.
Kuno I; Yoshida H; Shimizu H; Uehara T; Uno M; Ishikawa M; Kato T
Eur J Obstet Gynecol Reprod Biol; 2018 Dec; 231():93-97. PubMed ID: 30336310
[TBL] [Abstract][Full Text] [Related]
6. A second hit somatic (p.R905W) and a novel germline intron-mutation of TSC2 gene is found in intestinal lymphangioleiomyomatosis: a case report with literature review.
Han B; Lee J; Kwak YJ; Kim HY; Lee KH; Shim Y; Lee H; Park SH
Diagn Pathol; 2021 Aug; 16(1):83. PubMed ID: 34465349
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary lymphangioleiomyomatosis in tuberous sclerosis. A case report.
De Rosa N
Pathologica; 2009 Oct; 101(5):186-9. PubMed ID: 20218060
[TBL] [Abstract][Full Text] [Related]
8. Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis.
Smolarek TA; Wessner LL; McCormack FX; Mylet JC; Menon AG; Henske EP
Am J Hum Genet; 1998 Apr; 62(4):810-5. PubMed ID: 9529362
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of multifocal micronodular pneumocyte hyperplasia and lymphangioleiomyomatosis in tuberous sclerosis and association with tuberous sclerosis genes TSC1 and TSC2.
Maruyama H; Ohbayashi C; Hino O; Tsutsumi M; Konishi Y
Pathol Int; 2001 Aug; 51(8):585-94. PubMed ID: 11564212
[TBL] [Abstract][Full Text] [Related]
10. Selected case from the Arkadi M. Rywlin International Pathology Slide Seminar: Sporadic lymphangioleiomyomatosis.
Bisceglia M; D'Alessandro V; Simeone A; Ben-Dor D; Pasquinelli G
Adv Anat Pathol; 2010 Nov; 17(6):445-52. PubMed ID: 20966650
[TBL] [Abstract][Full Text] [Related]
11. Lymphangioleiomyomatosis.
Xu KF; Xu W; Liu S; Yu J; Tian X; Yang Y; Wang ST; Zhang W; Feng R; Zhang T
Semin Respir Crit Care Med; 2020 Apr; 41(2):256-268. PubMed ID: 32279296
[TBL] [Abstract][Full Text] [Related]
12. Mutation analysis of the TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis.
Sato T; Seyama K; Fujii H; Maruyama H; Setoguchi Y; Iwakami S; Fukuchi Y; Hino O
J Hum Genet; 2002; 47(1):20-8. PubMed ID: 11829138
[TBL] [Abstract][Full Text] [Related]
13. A patient with TSC1 germline mutation whose clinical phenotype was limited to lymphangioleiomyomatosis.
Sato T; Seyama K; Kumasaka T; Fujii H; Setoguchi Y; Shirai T; Tomino Y; Hino O; Fukuchi Y
J Intern Med; 2004 Aug; 256(2):166-73. PubMed ID: 15257730
[TBL] [Abstract][Full Text] [Related]
14. Clinical and histopathological alterations of lymphangioleiomyomatosis in 14 Chinese patients.
Lu SH; Hou YY; Tan YS; Xu JF; Zeng HY; Sujie AK; Wang XD; Bai CX
Chin Med J (Engl); 2009 Aug; 122(16):1895-900. PubMed ID: 19781367
[TBL] [Abstract][Full Text] [Related]
15. Clinical and molecular insights into lymphangioleiomyomatosis.
Steagall WK; Taveira-DaSilva AM; Moss J
Sarcoidosis Vasc Diffuse Lung Dis; 2005 Dec; 22 Suppl 1():S49-66. PubMed ID: 16457017
[TBL] [Abstract][Full Text] [Related]
16. Extrapulmonary uterine lymphangioleiomyomatosis (LAM) and dysfunctional uterine bleeding: the first presentation of LAM in a tuberous sclerosis complex patient.
Grant L; Chipwete S; Soo Hoo S; Bhatnagar A
BMJ Case Rep; 2019 Feb; 12(2):. PubMed ID: 30804158
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of uterine and adnexal involvement in pulmonary lymphangioleiomyomatosis: a clinicopathologic study of 10 patients.
Hayashi T; Kumasaka T; Mitani K; Terao Y; Watanabe M; Oide T; Nakatani Y; Hebisawa A; Konno R; Takahashi K; Yao T; Seyama K
Am J Surg Pathol; 2011 Dec; 35(12):1776-85. PubMed ID: 22020043
[TBL] [Abstract][Full Text] [Related]
18. Extrapulmonary lymphangioleiomyomatosis and lymphangiomatous cysts in tuberous sclerosis complex.
Torres VE; Björnsson J; King BF; Kumar R; Zincke H; Edell ES; Wilson TO; Hattery RR; Gomez MR
Mayo Clin Proc; 1995 Jul; 70(7):641-8. PubMed ID: 7791386
[TBL] [Abstract][Full Text] [Related]
19. Serum endostatin levels are associated with diffusion capacity and with tuberous sclerosis- associated lymphangioleiomyomatosis.
Lamattina AM; Poli S; Kidambi P; Bagwe S; Courtwright A; Louis PH; Shrestha S; Stump B; Goldberg HJ; Thiele EA; Rosas I; Henske EP; El-Chemaly S
Orphanet J Rare Dis; 2019 Mar; 14(1):72. PubMed ID: 30922357
[TBL] [Abstract][Full Text] [Related]
20. TSC2 epigenetic defect in primary LAM cells. Evidence of an anchorage-independent survival.
Lesma E; Ancona S; Sirchia SM; Orpianesi E; Grande V; Colapietro P; Chiaramonte E; Di Giulio AM; Gorio A
J Cell Mol Med; 2014 May; 18(5):766-79. PubMed ID: 24606538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]